Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19

Author(s):
Swen, J.J.; Straaten, T. van der; Wessels, J.A.M.; Bouvy, M.L.; Vlassak, E.E.W.; Assendelft, W.J.J.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2012
Publication type
Article / Letter to editor
PharmacogeneticsCytochrome P-450 CYP2D6Cytochrome P-450 CYP2C19Primary health care
Date issued
2012-04-30
Language
English
Is part of
European Journal of Clinical Pharmacology (2012), Vol. 68, no. 4, p. 363-370
hdl
1887/113432
doi
10.1007/s00228-011-1130-4